{"id": "article-27367_0", "title": "Viral Pneumonia -- Continuing Education Activity", "content": "The increasing role of viral pathogens in pneumonia and the increased recognition of bacterial and viral coinfections in patients with pneumonia necessitate a higher clinical index of suspicion and early identification of viral pulmonary pathogens. This activity describes the evaluation and management of viral pneumonia and highlights the role of the interprofessional team in improving care for affected patients.", "contents": "Viral Pneumonia -- Continuing Education Activity. The increasing role of viral pathogens in pneumonia and the increased recognition of bacterial and viral coinfections in patients with pneumonia necessitate a higher clinical index of suspicion and early identification of viral pulmonary pathogens. This activity describes the evaluation and management of viral pneumonia and highlights the role of the interprofessional team in improving care for affected patients."}
{"id": "article-27367_1", "title": "Viral Pneumonia -- Continuing Education Activity", "content": "Objectives: Describe the most common pathogens associated with viral pneumonia. Outline the typical presentation of a patient with viral pneumonia. Identify the type of viral pneumonia that can be prevented by vaccination. Outline the importance of collaboration among the interprofessional team to enhance patient care by educating patients about methods for preventing viral pneumonia. Access free multiple choice questions on this topic.", "contents": "Viral Pneumonia -- Continuing Education Activity. Objectives: Describe the most common pathogens associated with viral pneumonia. Outline the typical presentation of a patient with viral pneumonia. Identify the type of viral pneumonia that can be prevented by vaccination. Outline the importance of collaboration among the interprofessional team to enhance patient care by educating patients about methods for preventing viral pneumonia. Access free multiple choice questions on this topic."}
{"id": "article-27367_2", "title": "Viral Pneumonia -- Introduction", "content": "Viral pneumonia is defined as a disease entity wherein there is the viral causation of oxygen and carbon dioxide gas exchange abnormalities at the level of the alveoli, secondary to viral-mediated and/or immune response-mediated inflammation. The traditional role of viral pneumonia was as a disease found predominantly in the very\u00a0young, the elderly, and those exposed to influenza. In the past, the diagnosis of viral pneumonia was predicated on it being somewhat\u00a0a diagnosis of exclusion. History, physical exam, chest radiography, and available\u00a0lab work (until recently) lacked sensitivity and specificity. Once bacterial pneumonia has been excluded, then viral pneumonia diagnosis was entertained. [1] [2] [3] Traditionally, the treatment of viral pneumonia revolved around supportive care:", "contents": "Viral Pneumonia -- Introduction. Viral pneumonia is defined as a disease entity wherein there is the viral causation of oxygen and carbon dioxide gas exchange abnormalities at the level of the alveoli, secondary to viral-mediated and/or immune response-mediated inflammation. The traditional role of viral pneumonia was as a disease found predominantly in the very\u00a0young, the elderly, and those exposed to influenza. In the past, the diagnosis of viral pneumonia was predicated on it being somewhat\u00a0a diagnosis of exclusion. History, physical exam, chest radiography, and available\u00a0lab work (until recently) lacked sensitivity and specificity. Once bacterial pneumonia has been excluded, then viral pneumonia diagnosis was entertained. [1] [2] [3] Traditionally, the treatment of viral pneumonia revolved around supportive care:"}
{"id": "article-27367_3", "title": "Viral Pneumonia -- Introduction", "content": "Supplemental oxygen when\u00a0indicated Airway augmentation as appropriate Monitoring of and replacement of any fluid deficits Symptomatic control of temperature and cough Rest to reduce oxygen demand Treatment of any comorbidities and/or concomitant bacterial pneumonia The concepts of diagnosis, prevalence, clinical role, and treatment of viral pneumonia are in flux for several reasons. 1. There is a growing population at increased risk of viral pneumonia:", "contents": "Viral Pneumonia -- Introduction. Supplemental oxygen when\u00a0indicated Airway augmentation as appropriate Monitoring of and replacement of any fluid deficits Symptomatic control of temperature and cough Rest to reduce oxygen demand Treatment of any comorbidities and/or concomitant bacterial pneumonia The concepts of diagnosis, prevalence, clinical role, and treatment of viral pneumonia are in flux for several reasons. 1. There is a growing population at increased risk of viral pneumonia:"}
{"id": "article-27367_4", "title": "Viral Pneumonia -- Introduction", "content": "The increases in life span\u00a0and early infant survivability\u00a0have created an additional population at greater risk of viral pneumonia. The increased number of those receiving immune-impairing therapy (radiation and/or chemotherapy) for cancer. The increased use of disease-modifying\u00a0hematological/immunological agents\u00a0in chronic illness, resulting in secondary\u00a0impaired immunity. The advent of HIV The increase in the number of patients with inborn immune impairment serving bacterial infection secondary to antibiotic therapy. The increased incidence of organ transplantation and immunosuppressive therapy. 2. The availability of sensitive, specific, real-time-result-available testing for viral entities:", "contents": "Viral Pneumonia -- Introduction. The increases in life span\u00a0and early infant survivability\u00a0have created an additional population at greater risk of viral pneumonia. The increased number of those receiving immune-impairing therapy (radiation and/or chemotherapy) for cancer. The increased use of disease-modifying\u00a0hematological/immunological agents\u00a0in chronic illness, resulting in secondary\u00a0impaired immunity. The advent of HIV The increase in the number of patients with inborn immune impairment serving bacterial infection secondary to antibiotic therapy. The increased incidence of organ transplantation and immunosuppressive therapy. 2. The availability of sensitive, specific, real-time-result-available testing for viral entities:"}
{"id": "article-27367_5", "title": "Viral Pneumonia -- Introduction", "content": "Polymerase chain reaction (PCR) technology is replacing viral cultures and serial viral antigen titers. Both viral culture results and serial antigen testing were problematic because test results were not available\u00a0until weeks after the acute illness, and viral culturing for pneumonia could involve invasive sampling techniques to acquire. The availability of PCR\u00a0testing has resulted in increased testing\u00a0in general. The mechanism of PCR itself is more sensitive and specific because many viruses are notoriously difficult to grow in culture and are very sample dependent. 3. The positive feedback loop that results from improved viral pneumonia testing modalities: The test availability results\u00a0in an increased number of diagnoses. The increased number of diagnosis raises the clinical index of suspicion for the entity. The increased clinical index of suspicion raises the number of tests ordered. 4. The availability of safe, tolerable, and somewhat specific antiviral therapies:", "contents": "Viral Pneumonia -- Introduction. Polymerase chain reaction (PCR) technology is replacing viral cultures and serial viral antigen titers. Both viral culture results and serial antigen testing were problematic because test results were not available\u00a0until weeks after the acute illness, and viral culturing for pneumonia could involve invasive sampling techniques to acquire. The availability of PCR\u00a0testing has resulted in increased testing\u00a0in general. The mechanism of PCR itself is more sensitive and specific because many viruses are notoriously difficult to grow in culture and are very sample dependent. 3. The positive feedback loop that results from improved viral pneumonia testing modalities: The test availability results\u00a0in an increased number of diagnoses. The increased number of diagnosis raises the clinical index of suspicion for the entity. The increased clinical index of suspicion raises the number of tests ordered. 4. The availability of safe, tolerable, and somewhat specific antiviral therapies:"}
{"id": "article-27367_6", "title": "Viral Pneumonia -- Introduction", "content": "Prior viral pneumonia treatment was essentially supportive measures only. Initial efforts at antiviral therapy were not well tolerated. The availability of some specific and effective treatments now spur earlier testing and a greater appreciation of the role of viral infection in pneumonia. Disease-modifying therapy for HIV is now available.", "contents": "Viral Pneumonia -- Introduction. Prior viral pneumonia treatment was essentially supportive measures only. Initial efforts at antiviral therapy were not well tolerated. The availability of some specific and effective treatments now spur earlier testing and a greater appreciation of the role of viral infection in pneumonia. Disease-modifying therapy for HIV is now available."}
{"id": "article-27367_7", "title": "Viral Pneumonia -- Introduction", "content": "5. The\u00a0increasing role of viral pathogens in pneumonia and the increased realization of the role of bacterial and viral co-infection necessitate a higher clinical index of suspicion and early identification of viral pulmonary pathogens. Counterbalance seeing this new clinical burden is the availability of\u00a0the following: Enhanced laboratory detection via ELISA and PCR testing modalities Enhanced radiographic detection for a high thin section CAT scan An increasing number of safe and efficacious antiviral drugs Increased recognition\u00a0of the role of prevention in viral infectious disease.", "contents": "Viral Pneumonia -- Introduction. 5. The\u00a0increasing role of viral pathogens in pneumonia and the increased realization of the role of bacterial and viral co-infection necessitate a higher clinical index of suspicion and early identification of viral pulmonary pathogens. Counterbalance seeing this new clinical burden is the availability of\u00a0the following: Enhanced laboratory detection via ELISA and PCR testing modalities Enhanced radiographic detection for a high thin section CAT scan An increasing number of safe and efficacious antiviral drugs Increased recognition\u00a0of the role of prevention in viral infectious disease."}
{"id": "article-27367_8", "title": "Viral Pneumonia -- Etiology", "content": "As pneumonia can be considered somewhat a final common pathway of infection, especially for those who are immune-compromised, a great number of viruses can cause pneumonia. In general, these viruses can be divided into those containing DNA or RNA as their nucleic acid. As this is a bit of\u00a0an artificial division, a more meaningful approach to etiology is to define by clinical syndromes produced and demographics affected. [4] [5] [6]", "contents": "Viral Pneumonia -- Etiology. As pneumonia can be considered somewhat a final common pathway of infection, especially for those who are immune-compromised, a great number of viruses can cause pneumonia. In general, these viruses can be divided into those containing DNA or RNA as their nucleic acid. As this is a bit of\u00a0an artificial division, a more meaningful approach to etiology is to define by clinical syndromes produced and demographics affected. [4] [5] [6]"}
{"id": "article-27367_9", "title": "Viral Pneumonia -- Etiology -- Etiologies of Viral Influenza", "content": "Respiratory syncytial virus (RSV) RNA virus RSV is the most common cause of viral pneumonia in small children and infants. Rhinovirus RNA Rhinovirus is the most common cause of upper respiratory tract infection across all age groups, although\u00a0it is not as commonly represented\u00a0as a cause of viral pneumonia. Influenza A, B and C viruses RNA Influenza A is the greatest cause of mortality and morbidity among the viral types of\u00a0pneumonia. There are multiple subtypes of Influenza A.\u00a0 Two particularly concerning subtypes to be aware of are\u00a0the avian flu (H5N1)and swine flu\u00a0(H1N1). Human\u00a0metapneumovirus RNA Human Metapneumovirus is a novel viral pathogen that is increasingly recognized as a cause of viral pneumonia and is implicated as the cause of the SARS outbreak.", "contents": "Viral Pneumonia -- Etiology -- Etiologies of Viral Influenza. Respiratory syncytial virus (RSV) RNA virus RSV is the most common cause of viral pneumonia in small children and infants. Rhinovirus RNA Rhinovirus is the most common cause of upper respiratory tract infection across all age groups, although\u00a0it is not as commonly represented\u00a0as a cause of viral pneumonia. Influenza A, B and C viruses RNA Influenza A is the greatest cause of mortality and morbidity among the viral types of\u00a0pneumonia. There are multiple subtypes of Influenza A.\u00a0 Two particularly concerning subtypes to be aware of are\u00a0the avian flu (H5N1)and swine flu\u00a0(H1N1). Human\u00a0metapneumovirus RNA Human Metapneumovirus is a novel viral pathogen that is increasingly recognized as a cause of viral pneumonia and is implicated as the cause of the SARS outbreak."}
{"id": "article-27367_10", "title": "Viral Pneumonia -- Etiology -- Parainfluenza viruses type 1, 2, 3, and 4", "content": "RNA Parainfluenza virus has multiple serotypes and is most commonly associated with pneumonia-like illness in young children seasonally. Spring and fall predominate. Human bocavirus Coronavirus RNA Coronal viruses are already viruses that cause pneumonia, typically in immune incompetent people. However, one subtype of coronavirus is the virus causing Middle Eastern respiratory syndrome, and another has been implicated in severe acute respiratory syndrome. Adenovirus DNA Adenovirus most commonly causes pneumonia in people with solid organ transplantation or hematological transplantation Enteroviruses RNA Enteroviruses, although common causes of polio, gastrointestinal, and upper respiratory tract syndromes, are less common causes of viral pneumonia. Varicella-zoster virus", "contents": "Viral Pneumonia -- Etiology -- Parainfluenza viruses type 1, 2, 3, and 4. RNA Parainfluenza virus has multiple serotypes and is most commonly associated with pneumonia-like illness in young children seasonally. Spring and fall predominate. Human bocavirus Coronavirus RNA Coronal viruses are already viruses that cause pneumonia, typically in immune incompetent people. However, one subtype of coronavirus is the virus causing Middle Eastern respiratory syndrome, and another has been implicated in severe acute respiratory syndrome. Adenovirus DNA Adenovirus most commonly causes pneumonia in people with solid organ transplantation or hematological transplantation Enteroviruses RNA Enteroviruses, although common causes of polio, gastrointestinal, and upper respiratory tract syndromes, are less common causes of viral pneumonia. Varicella-zoster virus"}
{"id": "article-27367_11", "title": "Viral Pneumonia -- Etiology", "content": "DNA Varicella-zoster virus is associated with both chickenpox and shingles and may cause severe types of pneumonia, particularly in non-immune pregnant women, non-gravid-adults with chickenpox. It is a fairly common cause of pneumonia in people with HIV post-shingles outbreak Hantavirus RNA Hantavirus is a zoonotic viral pathogen that emerged in the American Southwest and is associated with rodent feces exposure. Hantavirus pneumonia is associated with frequent rapid respiratory failure and cardiovascular collapse. Parechoviruses Epstein-Barr virus (EBV) DNA Epstein-Barr virus, although commonly implicated in mono-like syndromes, can be rarely associated with viral pneumonia. The majority of which occur in people with hematological dyscrasias. Human herpesvirus 6 and 7 DNA Herpes simplex virus DNA HSV I and II\u00a0are both\u00a0associated\u00a0with viral pneumonia in immune-compromised patients, including those with HIV, solid organ transplantation, and hematopoietic transplantation.", "contents": "Viral Pneumonia -- Etiology. DNA Varicella-zoster virus is associated with both chickenpox and shingles and may cause severe types of pneumonia, particularly in non-immune pregnant women, non-gravid-adults with chickenpox. It is a fairly common cause of pneumonia in people with HIV post-shingles outbreak Hantavirus RNA Hantavirus is a zoonotic viral pathogen that emerged in the American Southwest and is associated with rodent feces exposure. Hantavirus pneumonia is associated with frequent rapid respiratory failure and cardiovascular collapse. Parechoviruses Epstein-Barr virus (EBV) DNA Epstein-Barr virus, although commonly implicated in mono-like syndromes, can be rarely associated with viral pneumonia. The majority of which occur in people with hematological dyscrasias. Human herpesvirus 6 and 7 DNA Herpes simplex virus DNA HSV I and II\u00a0are both\u00a0associated\u00a0with viral pneumonia in immune-compromised patients, including those with HIV, solid organ transplantation, and hematopoietic transplantation."}
{"id": "article-27367_12", "title": "Viral Pneumonia -- Etiology", "content": "Minimi virus Cytomegalovirus (CMV) DNA CMV is a significant cause of pneumonia in HIV-infected patients with a CD4 count less than 100 cells per millimeter squared. CMV is also frequently implicated in pneumonia in recipients of solid organ transplant and hematopoietic transplant. Measles RNA A childhood exanthemata\u2019s illness that, although less common in the industrialized world secondary to vaccination,\u00a0remains a major contributor to worldwide childhood mortality secondary to viral pneumonia as a sequela.", "contents": "Viral Pneumonia -- Etiology. Minimi virus Cytomegalovirus (CMV) DNA CMV is a significant cause of pneumonia in HIV-infected patients with a CD4 count less than 100 cells per millimeter squared. CMV is also frequently implicated in pneumonia in recipients of solid organ transplant and hematopoietic transplant. Measles RNA A childhood exanthemata\u2019s illness that, although less common in the industrialized world secondary to vaccination,\u00a0remains a major contributor to worldwide childhood mortality secondary to viral pneumonia as a sequela."}
{"id": "article-27367_13", "title": "Viral Pneumonia -- Etiology -- Middle East Respiratory Syndrome (Coronavirus)", "content": "RNA A\u00a0subset of the coronavirus associated with severe pneumonia. This was first observed in the Middle East and had an initial mortality rate of 30%. Severe Acute Respiratory Syndrome (Metapneumovirus) RNA A subset of Coronavirus causing life-threatening pneumonia", "contents": "Viral Pneumonia -- Etiology -- Middle East Respiratory Syndrome (Coronavirus). RNA A\u00a0subset of the coronavirus associated with severe pneumonia. This was first observed in the Middle East and had an initial mortality rate of 30%. Severe Acute Respiratory Syndrome (Metapneumovirus) RNA A subset of Coronavirus causing life-threatening pneumonia"}
{"id": "article-27367_14", "title": "Viral Pneumonia -- Epidemiology", "content": "A number of epidemiological cues can\u00a0aid in the diagnosis of viral pneumonia, including\u00a0the following:", "contents": "Viral Pneumonia -- Epidemiology. A number of epidemiological cues can\u00a0aid in the diagnosis of viral pneumonia, including\u00a0the following:"}
{"id": "article-27367_15", "title": "Viral Pneumonia -- Epidemiology", "content": "Age - Viral pneumonia is most common in the very\u00a0young and in the elderly.\u00a0 There is a steep decline in the incidence of viral pneumonia from adolescence through the fifth or sixth decade of life. Then an upsurge as age-related immunosuppression and age-related\u00a0pathologies result in immunosuppression increase. [7] [8] [9]", "contents": "Viral Pneumonia -- Epidemiology. Age - Viral pneumonia is most common in the very\u00a0young and in the elderly.\u00a0 There is a steep decline in the incidence of viral pneumonia from adolescence through the fifth or sixth decade of life. Then an upsurge as age-related immunosuppression and age-related\u00a0pathologies result in immunosuppression increase. [7] [8] [9]"}
{"id": "article-27367_16", "title": "Viral Pneumonia -- Epidemiology", "content": "Pregnancy - Viral pneumonia continues to be quite concerning in pregnancy. Of particular concern is influenza-related pneumonia secondary to the ubiquitous nature of influenza from late fall to late spring; the last two major flu epidemics, 1918\u00a0and 1957, produced respective mortality rates of 50% and 10%. This increased mortality is a major factor in the CDC recommendation that all otherwise healthy women\u00a0receive an inactivated influenza virus vaccine\u00a0during the second and third trimesters of pregnancy. An additional, though less common, cause of viral pneumonia in pregnant women is varicella. Limited data reflects a very\u00a0substantial mortality rate, and current recommendations are for treatment with varicella-zoster immune globulin within 96 hours\u00a0of exposure to varicella in a non-immune gravid\u00a0female. Immune competence - Decreased immune competence can be a result of\u00a0the following:", "contents": "Viral Pneumonia -- Epidemiology. Pregnancy - Viral pneumonia continues to be quite concerning in pregnancy. Of particular concern is influenza-related pneumonia secondary to the ubiquitous nature of influenza from late fall to late spring; the last two major flu epidemics, 1918\u00a0and 1957, produced respective mortality rates of 50% and 10%. This increased mortality is a major factor in the CDC recommendation that all otherwise healthy women\u00a0receive an inactivated influenza virus vaccine\u00a0during the second and third trimesters of pregnancy. An additional, though less common, cause of viral pneumonia in pregnant women is varicella. Limited data reflects a very\u00a0substantial mortality rate, and current recommendations are for treatment with varicella-zoster immune globulin within 96 hours\u00a0of exposure to varicella in a non-immune gravid\u00a0female. Immune competence - Decreased immune competence can be a result of\u00a0the following:"}
{"id": "article-27367_17", "title": "Viral Pneumonia -- Epidemiology", "content": "Chemotherapy (and/or) radiation therapy for neoplasm Treatment of chronic inflammatory illness with immunosuppressive therapy Organ transplantation requiring\u00a0immunosuppressive medications Acquired immune incompetence secondary to HIV Inherited diseases of diminished immune competency The aforementioned may result in increased susceptibility to viral pneumonia. Comorbid\u00a0circumstances - A\u00a0number of comorbid circumstances can predispose patients to viral pneumonia including: Trauma Severe burns Uncontrolled diabetes Malnutrition Poverty Environmental exposure Group living", "contents": "Viral Pneumonia -- Epidemiology. Chemotherapy (and/or) radiation therapy for neoplasm Treatment of chronic inflammatory illness with immunosuppressive therapy Organ transplantation requiring\u00a0immunosuppressive medications Acquired immune incompetence secondary to HIV Inherited diseases of diminished immune competency The aforementioned may result in increased susceptibility to viral pneumonia. Comorbid\u00a0circumstances - A\u00a0number of comorbid circumstances can predispose patients to viral pneumonia including: Trauma Severe burns Uncontrolled diabetes Malnutrition Poverty Environmental exposure Group living"}
{"id": "article-27367_18", "title": "Viral Pneumonia -- Pathophysiology", "content": "On a macroscopic level, viral pneumonia can occur through one of three mechanisms: Direct inoculation of viral particle into the lung (e.g., RSV or influenza) Spread in a contiguous fashion from viral infections\u00a0near the upper respiratory tract (e.g., measles) Hematogenous spread from a distant viral infection (e.g., CMV) On a microscopic level, the general pattern of viral pneumonia pathogenesis is as follows. Note that individual viral species causing pneumonia\u00a0will have some\u00a0variation from this scheme.", "contents": "Viral Pneumonia -- Pathophysiology. On a macroscopic level, viral pneumonia can occur through one of three mechanisms: Direct inoculation of viral particle into the lung (e.g., RSV or influenza) Spread in a contiguous fashion from viral infections\u00a0near the upper respiratory tract (e.g., measles) Hematogenous spread from a distant viral infection (e.g., CMV) On a microscopic level, the general pattern of viral pneumonia pathogenesis is as follows. Note that individual viral species causing pneumonia\u00a0will have some\u00a0variation from this scheme."}
{"id": "article-27367_19", "title": "Viral Pneumonia -- Pathophysiology", "content": "The target cell is the pneumocyte with resultant alveolar damage. The submucosa of the alveoli is targeted, causing inflammation and secondary edema, microhemorrhage, and cellular immune reaction. The cellular reaction consists of mononuclear lymphocytes and progresses to PMNs recruitment. Fibrin is released. Both CD4 and CD8 cells are involved, beginning a cascade of immune product secretion that can end in increased vascular permeability and resultant edema. This process may lead to intra-alveolar organization and an obliterans clinical picture. The far end of the spectrum of the process includes interstitial pneumonia, pulmonary edema, and cardiogenic shock.", "contents": "Viral Pneumonia -- Pathophysiology. The target cell is the pneumocyte with resultant alveolar damage. The submucosa of the alveoli is targeted, causing inflammation and secondary edema, microhemorrhage, and cellular immune reaction. The cellular reaction consists of mononuclear lymphocytes and progresses to PMNs recruitment. Fibrin is released. Both CD4 and CD8 cells are involved, beginning a cascade of immune product secretion that can end in increased vascular permeability and resultant edema. This process may lead to intra-alveolar organization and an obliterans clinical picture. The far end of the spectrum of the process includes interstitial pneumonia, pulmonary edema, and cardiogenic shock."}
{"id": "article-27367_20", "title": "Viral Pneumonia -- History and Physical", "content": "There are no pathognomonic history cues for the diagnosis of viral pneumonia as opposed to bacterial pneumonia. However,\u00a0cues\u00a0are suggestive in the differential diagnosis of viral pneumonia: Gradual onset as opposed to the sudden onset of symptoms. Lower temperature Lack of purulent sputum History of immunosuppression Prodromal viral upper respiratory tract illness History of HIV History of solid organ transplantation or hematopoietic transplantation History of neoplasm Concomitant flu symptoms Concomitant gastrointestinal symptoms", "contents": "Viral Pneumonia -- History and Physical. There are no pathognomonic history cues for the diagnosis of viral pneumonia as opposed to bacterial pneumonia. However,\u00a0cues\u00a0are suggestive in the differential diagnosis of viral pneumonia: Gradual onset as opposed to the sudden onset of symptoms. Lower temperature Lack of purulent sputum History of immunosuppression Prodromal viral upper respiratory tract illness History of HIV History of solid organ transplantation or hematopoietic transplantation History of neoplasm Concomitant flu symptoms Concomitant gastrointestinal symptoms"}
{"id": "article-27367_21", "title": "Viral Pneumonia -- History and Physical", "content": "There are no pathognomonic physical examination findings for the diagnosis of viral pneumonia as opposed to bacterial pneumonia. However, physical findings\u00a0are suggestive in the differential diagnosis of viral pneumonia: Tachycardia or tachypnea out of proportion to the temperature Temperature elevation disproportionately low to the level of debility Concomitant upper respiratory tract infection Rash The paucity of physical findings on\u00a0pulmonary exam disproportionate to the level of debility Bilateral positive lung findings", "contents": "Viral Pneumonia -- History and Physical. There are no pathognomonic physical examination findings for the diagnosis of viral pneumonia as opposed to bacterial pneumonia. However, physical findings\u00a0are suggestive in the differential diagnosis of viral pneumonia: Tachycardia or tachypnea out of proportion to the temperature Temperature elevation disproportionately low to the level of debility Concomitant upper respiratory tract infection Rash The paucity of physical findings on\u00a0pulmonary exam disproportionate to the level of debility Bilateral positive lung findings"}
{"id": "article-27367_22", "title": "Viral Pneumonia -- Evaluation", "content": "As noted above, both history and physical examination may provide few diagnostic cues as to the etiology of pneumonia (bacterial versus virus). With the existence of specific effective treatment modalities, diagnoses of and identification of viruses causing pneumonia is of increased importance. Fortunately, the diagnostic acuity of\u00a0laboratory examination in combination with radiography and history and physical examination has progressed. [10] [11] [12] Laboratory Examination CBC with differential - There are no absolute diagnostic findings as viral pneumonia may result in elevated, normal, or decreased WBC counts. However, viral etiology is less commonly associated with elevated WBC and \"left shifts\" of the differential than bacterial types of pneumonia. Chemistry panel - Useful for gauging the degree of\u00a0dehydration, relative renal dysfunction, and dosing of renal excreted medications C-reactive protein - As a reactive phase reactant, the CRP level may be elevated with viral pneumonia, although this is not a specific or sensitive finding. ELISA - rapid antigen tests - ELISA tests allow real-time data for a number of viral pneumonia pathogens. Commonly available ELISA tests include\u00a0the following:", "contents": "Viral Pneumonia -- Evaluation. As noted above, both history and physical examination may provide few diagnostic cues as to the etiology of pneumonia (bacterial versus virus). With the existence of specific effective treatment modalities, diagnoses of and identification of viruses causing pneumonia is of increased importance. Fortunately, the diagnostic acuity of\u00a0laboratory examination in combination with radiography and history and physical examination has progressed. [10] [11] [12] Laboratory Examination CBC with differential - There are no absolute diagnostic findings as viral pneumonia may result in elevated, normal, or decreased WBC counts. However, viral etiology is less commonly associated with elevated WBC and \"left shifts\" of the differential than bacterial types of pneumonia. Chemistry panel - Useful for gauging the degree of\u00a0dehydration, relative renal dysfunction, and dosing of renal excreted medications C-reactive protein - As a reactive phase reactant, the CRP level may be elevated with viral pneumonia, although this is not a specific or sensitive finding. ELISA - rapid antigen tests - ELISA tests allow real-time data for a number of viral pneumonia pathogens. Commonly available ELISA tests include\u00a0the following:"}
{"id": "article-27367_23", "title": "Viral Pneumonia -- Evaluation", "content": "Herpes simplex virus (HSV) Respiratory syncytial virus (RSV) Influenza A and B Cytomegalovirus (CMV)", "contents": "Viral Pneumonia -- Evaluation. Herpes simplex virus (HSV) Respiratory syncytial virus (RSV) Influenza A and B Cytomegalovirus (CMV)"}
{"id": "article-27367_24", "title": "Viral Pneumonia -- Evaluation", "content": "A caveat is that many viruses may be detected via ELISA in the presence of other known bacterial pathogens, and in some cases, the detection of a viral pathogen does not always indicate active disease. Gene amplification - First and second-generation PCR testing exists and may allow viral pneumonia etiology diagnosis within clinically relevant timing.\u00a0 Clinically available tests using PCR\u00a0methodology include\u00a0the following: CMV RSV HPV Coronal viruses", "contents": "Viral Pneumonia -- Evaluation. A caveat is that many viruses may be detected via ELISA in the presence of other known bacterial pathogens, and in some cases, the detection of a viral pathogen does not always indicate active disease. Gene amplification - First and second-generation PCR testing exists and may allow viral pneumonia etiology diagnosis within clinically relevant timing.\u00a0 Clinically available tests using PCR\u00a0methodology include\u00a0the following: CMV RSV HPV Coronal viruses"}
{"id": "article-27367_25", "title": "Viral Pneumonia -- Evaluation", "content": "Cytological\u00a0evaluation - No single cytological evaluation of patient tissue cells\u00a0is entirely diagnostic for viral pneumonia. However,\u00a0the\u00a0generalization can be made that DNA viruses typically produce intra-nuclear inclusions, and RNA viruses typically produce cytoplasmic inclusions. Viral culture - Although viral cultures are the gold standard for the\u00a0final diagnosis of viral pneumonia, there are limitations such as\u00a0the following: Viral cultures are routinely not available for 10 to 15 days, which limits them for acute clinical care decisions. The cultures are very dependent on obtaining a valid specimen. The success of delivering a viable specimen to the lab varies as many of the viruses have very\u00a0specific transport requirements. The fastidious nature of some viral pathogens limits the validity of a negative culture result.", "contents": "Viral Pneumonia -- Evaluation. Cytological\u00a0evaluation - No single cytological evaluation of patient tissue cells\u00a0is entirely diagnostic for viral pneumonia. However,\u00a0the\u00a0generalization can be made that DNA viruses typically produce intra-nuclear inclusions, and RNA viruses typically produce cytoplasmic inclusions. Viral culture - Although viral cultures are the gold standard for the\u00a0final diagnosis of viral pneumonia, there are limitations such as\u00a0the following: Viral cultures are routinely not available for 10 to 15 days, which limits them for acute clinical care decisions. The cultures are very dependent on obtaining a valid specimen. The success of delivering a viable specimen to the lab varies as many of the viruses have very\u00a0specific transport requirements. The fastidious nature of some viral pathogens limits the validity of a negative culture result."}
{"id": "article-27367_26", "title": "Viral Pneumonia -- Evaluation", "content": "Viral antigens serology - The great majority of the viral entities involved in viral pneumonia have serological markers that can be obtained in the tract. Diagnostic problems include positive serology obtained for people with chronic viral infections that are not a factor in the presence of pneumonia and the limited use in acute treatment and decision making of viral pneumonia. Chest x-ray - As there is a tremendous overlap in findings on chest x-ray with both bacterial pneumonia and viral pneumonia, no one finding\u00a0or set of findings is pathognomonic. Features that are\u00a0suggestive of bacterial pneumonia include\u00a0the following: Alveolar infiltrates Lobar consolidation Nodular densities Pleural effusion Features that are more suggestive of viral pneumonia include\u00a0the following: Interstitial infiltrates Patchy distribution of interstitial infiltrates Bilateral infiltrates Pneumonia-like syndrome with an unremarkable chest x-ray", "contents": "Viral Pneumonia -- Evaluation. Viral antigens serology - The great majority of the viral entities involved in viral pneumonia have serological markers that can be obtained in the tract. Diagnostic problems include positive serology obtained for people with chronic viral infections that are not a factor in the presence of pneumonia and the limited use in acute treatment and decision making of viral pneumonia. Chest x-ray - As there is a tremendous overlap in findings on chest x-ray with both bacterial pneumonia and viral pneumonia, no one finding\u00a0or set of findings is pathognomonic. Features that are\u00a0suggestive of bacterial pneumonia include\u00a0the following: Alveolar infiltrates Lobar consolidation Nodular densities Pleural effusion Features that are more suggestive of viral pneumonia include\u00a0the following: Interstitial infiltrates Patchy distribution of interstitial infiltrates Bilateral infiltrates Pneumonia-like syndrome with an unremarkable chest x-ray"}
{"id": "article-27367_27", "title": "Viral Pneumonia -- Evaluation", "content": "Chest CT scan - The advent of thin-section CT scan has revolutionized the radiographic diagnosis of viral pneumonia. It has been observed, particularly in cases of viral pneumonia-like clinical presentation and normal chest radiography, thin-section CT scan will be positive for parenchymal defects and aid in diagnosis.", "contents": "Viral Pneumonia -- Evaluation. Chest CT scan - The advent of thin-section CT scan has revolutionized the radiographic diagnosis of viral pneumonia. It has been observed, particularly in cases of viral pneumonia-like clinical presentation and normal chest radiography, thin-section CT scan will be positive for parenchymal defects and aid in diagnosis."}
{"id": "article-27367_28", "title": "Viral Pneumonia -- Treatment / Management -- The cornerstone of treatment of viral pneumonia consists of\u00a0the following: Supportive Care", "content": "The first\u00a0priority of supportive care is to maintain oxygenation as needed. This may entail nasal cannula, noninvasive airway, or mechanical ventilation. The second priority of supportive care is to maintain hydration either via supervised oral intake or intravenous fluids. The third priority of supportive care is to maintain rest and decrease oxygen demand. A final priority of supportive care is to meet the increased calorie needs of the patient, secondary to the increased respiratory effort. Management of Comorbid Illnesses Appropriate treatment of Coexisting Bacterial Types of Pneumonia", "contents": "Viral Pneumonia -- Treatment / Management -- The cornerstone of treatment of viral pneumonia consists of\u00a0the following: Supportive Care. The first\u00a0priority of supportive care is to maintain oxygenation as needed. This may entail nasal cannula, noninvasive airway, or mechanical ventilation. The second priority of supportive care is to maintain hydration either via supervised oral intake or intravenous fluids. The third priority of supportive care is to maintain rest and decrease oxygen demand. A final priority of supportive care is to meet the increased calorie needs of the patient, secondary to the increased respiratory effort. Management of Comorbid Illnesses Appropriate treatment of Coexisting Bacterial Types of Pneumonia"}
{"id": "article-27367_29", "title": "Viral Pneumonia -- Treatment / Management", "content": "Most current evidence indicates the frequent existence of concomitant bacterial types of pneumonia. The prototypical example is the observation that the majority of mortality during the 1917-1918 influenza pandemic was secondary to bacterial pneumonia, superimposed on the initial influenza pneumonia. [13] [14] [15] Specific antiviral therapy for a number of viral pneumonia exists as does preventative or prophylactic therapies for those at high risk would have been exposed: Influenza virus Treatment: Oseltamivir or\u00a0peramivir\u00a0or zanamivir Prophylaxis: Influenza vaccine and/or\u00a0chemoprophylaxis with\u00a0zanamivir\u00a0or oseltamivir Respiratory syncytial virus (RSV) Treatment: Ribavirin Prophylaxis: RSV immunoglobulin and/or\u00a0palivizumab Parainfluenza virus Treatment: Ribavirin Prophylaxis: Not available Herpes simplex virus (HSV) Treatment: Acyclovir Prophylaxis: Not available Adenovirus Treatment: Ribavirin Prophylaxis: Not available Measles virus", "contents": "Viral Pneumonia -- Treatment / Management. Most current evidence indicates the frequent existence of concomitant bacterial types of pneumonia. The prototypical example is the observation that the majority of mortality during the 1917-1918 influenza pandemic was secondary to bacterial pneumonia, superimposed on the initial influenza pneumonia. [13] [14] [15] Specific antiviral therapy for a number of viral pneumonia exists as does preventative or prophylactic therapies for those at high risk would have been exposed: Influenza virus Treatment: Oseltamivir or\u00a0peramivir\u00a0or zanamivir Prophylaxis: Influenza vaccine and/or\u00a0chemoprophylaxis with\u00a0zanamivir\u00a0or oseltamivir Respiratory syncytial virus (RSV) Treatment: Ribavirin Prophylaxis: RSV immunoglobulin and/or\u00a0palivizumab Parainfluenza virus Treatment: Ribavirin Prophylaxis: Not available Herpes simplex virus (HSV) Treatment: Acyclovir Prophylaxis: Not available Adenovirus Treatment: Ribavirin Prophylaxis: Not available Measles virus"}
{"id": "article-27367_30", "title": "Viral Pneumonia -- Treatment / Management", "content": "Treatment: Ribavirin Prophylaxis: intravenous immunoglobulin Cytomegalovirus (CMV) Treatment: Ganciclovir or\u00a0foscarnet Prophylaxis: intravenous immunoglobulin Varicella-zoster virus (VZ) Treatment: Acyclovir Prophylaxis:\u00a0Varicella-zoster immunoglobulin (VZIG)", "contents": "Viral Pneumonia -- Treatment / Management. Treatment: Ribavirin Prophylaxis: intravenous immunoglobulin Cytomegalovirus (CMV) Treatment: Ganciclovir or\u00a0foscarnet Prophylaxis: intravenous immunoglobulin Varicella-zoster virus (VZ) Treatment: Acyclovir Prophylaxis:\u00a0Varicella-zoster immunoglobulin (VZIG)"}
{"id": "article-27367_31", "title": "Viral Pneumonia -- Differential Diagnosis", "content": "The differential diagnosis for viral pneumonia is broad and includes\u00a0the following: Bacterial pneumonia Bacterial or viral bronchitis Fungal pneumonia Lipoid pneumonia Sarcoidosis Amyloidosis Pulmonary edema Congestive heart failure Pulmonary embolism Pulmonary hypertension Pulmonary fibrosis Hyperreactive airway disease", "contents": "Viral Pneumonia -- Differential Diagnosis. The differential diagnosis for viral pneumonia is broad and includes\u00a0the following: Bacterial pneumonia Bacterial or viral bronchitis Fungal pneumonia Lipoid pneumonia Sarcoidosis Amyloidosis Pulmonary edema Congestive heart failure Pulmonary embolism Pulmonary hypertension Pulmonary fibrosis Hyperreactive airway disease"}
{"id": "article-27367_32", "title": "Viral Pneumonia -- Prognosis", "content": "Multiple variables determine the prognosis of each case of viral pneumonia, such as\u00a0the following: The\u00a0relative for\u00a0virulence of the\u00a0species of infecting virus-for example, hantavirus, SARS, or MERS carries a much worse prognosis than RSV or influenza virus. The immune competence of the patient such that immune impaired patients with HIV carry a much worse prognosis than a gravid female or a previously well, immuno-competent baby. The underlying pathologies of the patient, such as\u00a0the presence of\u00a0COPD, congestive heart failure, diabetes, cancer, and/or hematological dyscrasias, greatly\u00a0increases the anticipated morbidity and mortality. The presence or absence of concomitant bacterial infection The relative point during the infective process at which diagnosis was made and definitive treatment started (if available).", "contents": "Viral Pneumonia -- Prognosis. Multiple variables determine the prognosis of each case of viral pneumonia, such as\u00a0the following: The\u00a0relative for\u00a0virulence of the\u00a0species of infecting virus-for example, hantavirus, SARS, or MERS carries a much worse prognosis than RSV or influenza virus. The immune competence of the patient such that immune impaired patients with HIV carry a much worse prognosis than a gravid female or a previously well, immuno-competent baby. The underlying pathologies of the patient, such as\u00a0the presence of\u00a0COPD, congestive heart failure, diabetes, cancer, and/or hematological dyscrasias, greatly\u00a0increases the anticipated morbidity and mortality. The presence or absence of concomitant bacterial infection The relative point during the infective process at which diagnosis was made and definitive treatment started (if available)."}
{"id": "article-27367_33", "title": "Viral Pneumonia -- Complications", "content": "Complications of viral pneumonia include\u00a0the following: Concomitant bacterial infection, resulting in an abscess, empyema, and or pleural effusion Sepsis with secondary multiple organ failure Acute respiratory failure Cardiovascular collapse Acute respiratory distress syndrome", "contents": "Viral Pneumonia -- Complications. Complications of viral pneumonia include\u00a0the following: Concomitant bacterial infection, resulting in an abscess, empyema, and or pleural effusion Sepsis with secondary multiple organ failure Acute respiratory failure Cardiovascular collapse Acute respiratory distress syndrome"}
{"id": "article-27367_34", "title": "Viral Pneumonia -- Consultations", "content": "Consultation with infectious disease specialists can be useful in both ascertaining the etiology of viral pneumonia and its relative clinical role if bacterial co-infection\u00a0is suspected. Consultation with a pulmonary/critical\u00a0care\u00a0physician is advisable if the patient is hypoxic or requires advanced airway or placement in a critical care setting.", "contents": "Viral Pneumonia -- Consultations. Consultation with infectious disease specialists can be useful in both ascertaining the etiology of viral pneumonia and its relative clinical role if bacterial co-infection\u00a0is suspected. Consultation with a pulmonary/critical\u00a0care\u00a0physician is advisable if the patient is hypoxic or requires advanced airway or placement in a critical care setting."}
{"id": "article-27367_35", "title": "Viral Pneumonia -- Deterrence and Patient Education", "content": "Patient education and preventative medicine play a key role in the clinical management of viral pneumonia: Education to promote universal vaccination against measles and varicella Education to promote appropriate\u00a0influenza vaccination and post-exposure prophylaxis Education of prenatal patient's about influenza and varicella immunity HIV prevention and CD4 count surveillance with appropriate\u00a0prophylaxis Education and surveillance of the chronically immunosuppressed, including those\u00a0receiving chemotherapy, radiation therapy, immunosuppressive drugs", "contents": "Viral Pneumonia -- Deterrence and Patient Education. Patient education and preventative medicine play a key role in the clinical management of viral pneumonia: Education to promote universal vaccination against measles and varicella Education to promote appropriate\u00a0influenza vaccination and post-exposure prophylaxis Education of prenatal patient's about influenza and varicella immunity HIV prevention and CD4 count surveillance with appropriate\u00a0prophylaxis Education and surveillance of the chronically immunosuppressed, including those\u00a0receiving chemotherapy, radiation therapy, immunosuppressive drugs"}
{"id": "article-27367_36", "title": "Viral Pneumonia -- Pearls and Other Issues", "content": "The role of viruses\u00a0in primary pneumonia is increasing, and\u00a0viral respiratory pathogens are increasingly recognized as a cofactor in bacterial pneumonia secondary to the increasing prevalence of immunosuppression-cancer treatment, organ transplant, and HIV. Prevention, especially in the form of immunization against influenza and measles, can significantly decrease the\u00a0incidence of viral pneumonia. Increasingly, specific and sensitive real-time diagnostic laboratory tools are available in the form of ELISA and PCR modalities for the specific diagnosis of viral pneumonia and assignment of specific treatment when existent. Although there are no pathognomonic history or physical findings for viral pneumonia as opposed to bacterial pneumonia, there are a number of clinical cues that are quite\u00a0suggestive. Although specific antiviral agents do\u00a0exist, the cornerstone of treatment for viral pneumonia remains supportive care.", "contents": "Viral Pneumonia -- Pearls and Other Issues. The role of viruses\u00a0in primary pneumonia is increasing, and\u00a0viral respiratory pathogens are increasingly recognized as a cofactor in bacterial pneumonia secondary to the increasing prevalence of immunosuppression-cancer treatment, organ transplant, and HIV. Prevention, especially in the form of immunization against influenza and measles, can significantly decrease the\u00a0incidence of viral pneumonia. Increasingly, specific and sensitive real-time diagnostic laboratory tools are available in the form of ELISA and PCR modalities for the specific diagnosis of viral pneumonia and assignment of specific treatment when existent. Although there are no pathognomonic history or physical findings for viral pneumonia as opposed to bacterial pneumonia, there are a number of clinical cues that are quite\u00a0suggestive. Although specific antiviral agents do\u00a0exist, the cornerstone of treatment for viral pneumonia remains supportive care."}
{"id": "article-27367_37", "title": "Viral Pneumonia -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional team of healthcare workers manages viral pneumonia. While physicians may treat the infection, the role of the nurse and pharmacist are vital for prevention. The patient should be urged to get the annual influenza vaccine, as this can lower the morbidity and mortality. Pharmacists review prescriptions for dose and interactions and educate patients about side effects and the importance of compliance. All patients should be urged to quit smoking and abstain from alcohol. Further, patients should be educated about hand and personal hygiene to prevent transmission of the virus to others. Patients who are immunocompromised should be educated about the symptoms of pneumonia and when to seek medical care. Finally, patients should be urged to lead a healthy lifestyle, eat healthily, and exercise regularly. Close communication between the interprofessional team is essential if one wants to improve outcomes. [16] [9] (Level 5)", "contents": "Viral Pneumonia -- Enhancing Healthcare Team Outcomes. An interprofessional team of healthcare workers manages viral pneumonia. While physicians may treat the infection, the role of the nurse and pharmacist are vital for prevention. The patient should be urged to get the annual influenza vaccine, as this can lower the morbidity and mortality. Pharmacists review prescriptions for dose and interactions and educate patients about side effects and the importance of compliance. All patients should be urged to quit smoking and abstain from alcohol. Further, patients should be educated about hand and personal hygiene to prevent transmission of the virus to others. Patients who are immunocompromised should be educated about the symptoms of pneumonia and when to seek medical care. Finally, patients should be urged to lead a healthy lifestyle, eat healthily, and exercise regularly. Close communication between the interprofessional team is essential if one wants to improve outcomes. [16] [9] (Level 5)"}
{"id": "article-27367_38", "title": "Viral Pneumonia -- Enhancing Healthcare Team Outcomes -- Outcomes", "content": "The outcomes in most healthy people with viral pneumonia are excellent. However, in individuals who are immunocompromised or at extremes of age, the\u00a0prognosis is guarded. Several adenovirus\u00a0serotypes are known to\u00a0cause severe pneumonia leading to bronchiectasis and irreversible atelectasis. It\u00a0is estimated that anywhere from 10%-40% of children may suffer some\u00a0irreversible\u00a0lung damage after adenovirus pneumonia. Viral pneumonia in a patient with an underlying disease can add morbidity and lead to marked hypoxia. Overall, most patients recover with supportive measures and have no residual sequelae. [17] [18] (Level 5)", "contents": "Viral Pneumonia -- Enhancing Healthcare Team Outcomes -- Outcomes. The outcomes in most healthy people with viral pneumonia are excellent. However, in individuals who are immunocompromised or at extremes of age, the\u00a0prognosis is guarded. Several adenovirus\u00a0serotypes are known to\u00a0cause severe pneumonia leading to bronchiectasis and irreversible atelectasis. It\u00a0is estimated that anywhere from 10%-40% of children may suffer some\u00a0irreversible\u00a0lung damage after adenovirus pneumonia. Viral pneumonia in a patient with an underlying disease can add morbidity and lead to marked hypoxia. Overall, most patients recover with supportive measures and have no residual sequelae. [17] [18] (Level 5)"}
{"id": "article-27367_39", "title": "Viral Pneumonia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Viral Pneumonia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}